FOXO1 and metabolic dysfunction-associated steatohepatitis: Hence, higher insulin secretion and downregulation of hepatic FOXO1 and its target genes in NASH‐HCC Spp1−/− mice could contribute to the beneficial effects of OPN deficiency on glucose metabolism, as also to the detrimental effect on hepatic lipid accumulation and toxicity.